论文信息 - Idarubicin in combination with intermediate-dose cytarabine and VP-16 in the treatment of refractory or rapidly relapsed patients with acute myeloid leukemia. The GIMEMA Cooperative Group. - 字舞流文

Idarubicin in combination with intermediate-dose cytarabine and VP-16 in the treatment of refractory or rapidly relapsed patients with acute myeloid leukemia. The GIMEMA Cooperative Group.

L. Pagano | M. Montillo | R. Stasi | A. Carella | P. Carlier | V. Liso | S. Mirto | E. Pungolino | P. Iacopino | L. Resegotti | E. Pungolino | Paolo Carlier | Luigi Resegotti | Liso | Pasquale Iacopino | Livio Pagano